Products

Pertuzumab 420mg/14mL Pharmaceutical Export from India to UAE Prime Care Impex is an authorised international buyer of pharmaceutical export enquiries from India to facilitate the export of oncology and speciality pharmaceutical products. We help clients across the United Arab Emirates (UAE), including Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain, with product sourcing and export coordination. One of our product focused export enquiries. Product: pertuzumab 420mg/14mL injection. Pertuzumab is a prescription oncology biologic, which contains pertuzumab. Pertuzumab 420mg/14mL Injection – Overview Pertuzumab is a recombinant humanised IgG1 monoclonal antibody made by recombinant DNA technology. The 420 mg/14 mL presentation contains 420 mg of pertuzumab in a 14 mL vial, which is a concentration of 30 mg/mL. Pertuzumab is a prescription medicine used in combination with other medicines to treat certain HER2-positive breast cancers. Product use, prescribing and administration should always be in accordance with the relevant product information and appropriately qualified health care professionals. Product details Specification Details Product Pertuzumab 420mg/14mL Injection Strength: 420 mg Volume Fill 14 ml Concentration 30 mg/mL Active Ingredient: Pertuzumab Pharmaceutical Class: Humanised IgG1. Monoclonal Antibody (mAb) Production Technology Genetic Engineering Dosage form Solution concentrate for infusion Pack Presentation 1 Vial Product Category Prescription Oncology Medicine Country of Origin India Target Market United Arab Emirates (UAE) Export Destination: UAE India to UAE Export Inquiry | Pharmaceutical Supplier Dubai Prime Care Impex receives UAE pharmaceutical supplier enquiries from authorised importers, pharmaceutical distributors, wholesalers, procurement companies and other eligible healthcare businesses looking for pharmaceutical products from India. Our India to UAE pharmaceutical export inquiry services may include. Sourcing enquiries for Pertuzumab 420mg/14mL Enquiries about product availability Questions about manufacturer and product documentation Batch and expiry details if applicable Commercial quotation requests Discussions on packaging and shipping Temperature-controlled logistics orchestration Documentation for export UAE importers/distributors coordination International pharmaceutical supply requests Prime Care Impex helps pharmaceutical export queries from India for clients in key locations of UAE including: Dubai Abu Dhabi Sharjah Ajman Ras Al Khaimah Fujairah Umm Al Quwain Whether you need to procure from Dubai, Abu Dhabi or another emirate in the UAE, our team can talk to you about product availability, documentation, quotation and export requirements. Pharmaceutical Export Services from India to UAE India is one of the world’s largest pharmaceutical manufacturing and exporting countries. Prime Care Impex helps in international pharmaceutical sourcing queries and export coordination from India. Our India to UAE Pharmaceutical Export Services enable authorised buyers to articulate their product specifications and negotiate suitable export arrangements. Buyers should be especially vigilant about speciality and biologic medicines, like pertuzumab, including product authenticity, documentation, cold chain requirements, packaging and regulatory compliance. Pertuzumab Supplier UAE Product Sourcing Enquiries If you are looking for a Pertuzumab supplier UAE or an India based pharmaceutical exporter for Pertuzumab 420mg/14mL, Prime Care Impex can receive your product sourcing inquiry. Prime Care Impex – Supplier of Pharmaceuticals in Dubai PRIME CARE IMPEX INDIA Official Website: medicineexporterfromindia.com Company Email: raakeshkashiwar@gmail.com Phone / WhatsApp: +91 9673008130 Chat With Us On WhatsApp : +91 9673008130 For any queries related to Pharmaceutical export from India to UAE, Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, please feel free to contact Prime Care Impex for more information on your requirement. UAE pharmaceutical supplier Additional Keywords Pertuzumab 420mg/14mL-UAE supplier Pertuzumab supplier in UAE Pertuzumab injection exporter in India Pertuzumab pharmaceutical exporter pharmaceutical exporter India to UAE pharmaceutical supplier Dubai pharmaceutical supplier Abu Dhabi pharmaceutical supplier Sharjah pharmaceutical export UAE India to UAE pharmaceutical export oncology medicine exporter India biologic medicine exporter India cancer medicine exporter India pharmaceutical export services UAE Pertuzumab 420mg supplier Pharmaceutical wholesale supplier UAE Indian pharmaceutical exporter UAE New Keyword Suggestion Pharmaceutical Supplier UAE Suggested complementary keyword/phrase UAE to India Pharmaceuticals Export Services Pertuzumab 420mg/14mL Exporters from India | Pharmaceutical Supplier Dubai

Perjeta 420mg/14mL Pertuzumab Pharmaceutical Exporter from India to US PRIME CARE IMPEX Supports Pharmaceuticals Export Enquiries from India to USA (New York, Los Angeles, Chicago, Houston, Miami, Dallas, San Francisco, Boston, Washington DC and other USA locations) Product Specification PERJETA 420mg/14mL Active ingredient: Pertuzumab Strength: 420 mg/14 mL Pack Size: 1 vial Form: Concentrate for solution for infusion **Category:** Anticancer Biologic / Oncology Export Origin: Indien Target Market: United States Description of Product Perjeta 420mg/14mL is a monoclonal antibody known as pertuzumab, which targets HER2, and is used in specific treatment scenarios for HER2-positive breast cancer. It is a prescription oncology medicine and should be handled and administered by qualified healthcare professionals in accordance with applicable product information. Note: Pertuzumab is not a hormone medicine, it is a targeted monoclonal antibody used in oncology. Pharmaceutical Exporting Services to USA India PRIME CARE IMPEX is inviting enquiries for India to USA pharmaceutical export including: Product sourcing enquiries Products available Enquiries on Quantity and Quotation Pharmaceuticals Documentation Co-ordination of exports Overseas Shipping Enquiries Sourcing Pharmaceuticals for Oncology Importers of pharmaceutical products for the United States should check the applicable FDA requirements, product approval status, establishment registration, drug listing, labelling, CGMP and other applicable regulatory requirements before importation. USA Pharmaceutical Supplier PRIME CARE IMPEX can take your product inquiry. If you are looking for a pharmaceutical supplier USA, Pertuzumab supplier, Perjeta 420mg/14mL supplier or pharmaceutical exporter India to USA. Please give: Product Name + Strength + Quantity + Destination USA + Buyer/Importer Information + Documentation Required This helps us to review the sourcing inquiry efficiently. Primary Keyword: Pharma Exporter India USA Keywords: Secondary Pharmaceutical Supplier USA, Pertuzumab Exporter India, Perjeta 420mg/14mL Supplier, Perjeta Pharmaceutical Exporter, Oncology Pharmaceutical Exporter India, Anticancer Medicine Exporter India, India to USA Pharmaceutical Export, Pharmaceutical Supplier India, Pharmaceutical Export Company India. Long tail keyword: Perjeta 420mg/14mL Pertuzumab Pharmaceutical Exporter from India to US Geographic Keywords USA Pharmaceutical Exporter New York • Pharmaceutical Exporter Los Angeles • Chicago Pharmaceutical Exporter • Pharmaceutical Exporter Houston • Pharmaceutical Exporter Miami • Pharmaceutical Exporter Dallas • Pharma Exporter San Francisco • Pharma Exporter Boston • Pharma Exporter Washington DC • Pharma Exporter Atlanta The import of pharmaceuticals into the United States is subject to applicable U.S. laws and FDA requirements. Availability of a product or export inquiry does not imply that a particular product is approved for commercial sale or importation into the USA. Buyers/importers should verify the applicable regulatory pathway prior to placing an order. Contact PRIME CARE IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone/WhatsApp: +91 9673008130 Perjeta 420mg/14mL Pertuzumab Exporter India to USA PRIME CARE IMPEX supports export enquiries of Perjeta 420mg/14mL Pertuzumab pharmaceutical from India to USA including New York, Los Angeles, Chicago, Houston and Miami. perjeta-420mg-14ml-pertuzumab-exporter-india-to-usa Recommended H1 Pharmaceutical Exporter India to USA – Perjeta 420mg/14mL Pertuzumab

Paraplatin Carboplatin Injection 450 mg Vial- Pharmaceutical Exporter India to USA Paraplatin Carboplatin for Injection 450 mg Vial is a pharmaceutical product for antineoplastic use, based on carboplatin, for use in specialist oncology settings under the supervision of an appropriate healthcare professional. Primecare Impex is a pharmaceutical export company based in India. We help in B2B pharmaceutical export enquiries for international buyers and authorised pharmaceutical companies looking for pharmaceutical products from India. We provide pharmaceutical export queries assistance to clients and business partners throughout the United States including New York, California, Texas, Florida, New Jersey, Illinois, Pennsylvania, Georgia, Massachusetts and other U.S. locations. Pharma Export Services from India to USA We offer India to USA pharmaceutical export services for genuine B2B pharmaceutical enquiries from American Buyers. We can help with pharmaceutical product enquiries from locations such as: NY • L. A. • Chicago, Illinois • Houston (HOU) Dallas • Miami • • New Jersey • Boston • Philadelphia • Atlanta • San Francisco Imported medicines in the United States are subject to certain regulatory requirements. Foreign establishments whose drugs are imported or offered for import into the U.S. may be required to register with the FDA and list applicable drug products. The imported product must meet applicable FDA requirements. Carboplatin 450 mg Vial Supplier in India Primecare Impex receives international B2B enquiries for Carboplatin 450 mg injection and other pharmaceutical products from India. We can provide buyers with information on: Carboplatin injection 450 mg Product availability Product Details Packaging arrangement Export paperwork Commercial Supply Enquiries Export Requirements for Pharmaceuticals from India to USA Please confirm product availability and eligibility for import into the United States before placing a commercial order. India Pharmaceutical Exporter & Oncological Primecare Impex offers support for international pharmaceutical enquiries for Oncology and Speciality pharmaceutical products. We aim to provide straightforward communication of product information, export documentation and commercial enquiries for authorised international buyers. The FDA is responsible for determining the admissibility of drug shipments for U.S. pharmaceutical imports. If an imported product appears to violate applicable federal requirements, the agency can refuse entry. Pharmaceutical Supplier USA – Pharmaceutical Provider in USA Paraplatin Carboplatin Injection 450 mg – Product Information Carboplatin is a platinum-based antineoplastic drug used in specialist cancer treatment. Use, dosage, administration and treatment regimen should be determined by qualified health care professionals. Product Information Specification Details Product Name Paraplatin Carboplatin for Injection Active Ingredient Carboplatin Strength 450 mg/vial Dosage Form Injection Therapeutic Category Antineoplastic / Oncology Product Type Pharmaceutical formulation Country of Origin India Export Market International / USA enquiries Supply Type B2B enquiries for pharma exports Product presentation, manufacturer information, packaging, batch documentation, regulatory status and market authorisation should be verified independently for the intended U.S. market prior to commercial importation. Pharmaceutical Exporter From India To US Primecare Impex assists with pharmaceutical export enquiries from India to the USA for authorised pharmaceutical companies, distributors, wholesalers and other eligible business buyers. Our pharmaceutical export enquiry services can include information relating to: Oncology pharmaceutical products injections pharmaceuticals Prescription drugs Product specifications Packaging information Batch and expiry details Documentation for Export Market quotes: International pharmaceutical supply questions Refers to drugs made available for import into the United States, with applicable FDA requirements met. The FDA says it may examine imported human drugs for compliance with requirements such as establishment registration, drug listing, applicable drug applications, labelling and current good manufacturing practices. Pharmaceutical Supplier Export Support India – USA Need a pharmaceutical supplier in the USA or a pharmaceutical exporter in India for USA enquiries? Primecare Impex is a B2B pharmaceutical export inquiry support provider to international customers who are interested in importing pharmaceuticals from India. New York pharmaceutical supplier California pharmaceutical supplier pharmaceutical supplier in Florida pharmaceutical supplier in Texas New Jersey Illinois pharmaceutical supplier Pennsylvania pharmaceutical supplier Georgia pharmaceutical supplier Maryland pharmaceutical supplier Pharmaceutical Supplier USA Pharmaceutical Supplier Los Ange

PACLITAX-100MG/16.7ML PACLITAXEL INJECTION – 100 mg/16.7 mL vial Paclitaxel Injection Exporter in India to USA Keywords: Secondary Naturally use these keywords in the article without keyword stuffing: Paclitaxel Injection Manufacturer in India SUPPLIER OF PACLITAXEL 100mg/16.7ml Paclitaxel Injection supplier USA Pharma Supplier India To USA Pharmaceutical exporter USA India, exporter of Oncology pharma (I) India Exporter of anticancer medicine Paclitaxel supplier of pharmaceutical India cancer medicine exporter Pharmaceutical export from India to USA USA pharmaceutical import supplier Supplier of oncology medicine Indian Pharmaceutical Export Company Wholesale supplier of Paclitaxel Injection Sourcing Pharmaceuticals from India Target Locations U.S. Create natural, location-based SEO sections that target: Los Angeles - New York • Chicago: • Houston, TX • Philadelphia • Phoenix • San Antonio • San Diego • Dallas • Austin • San Jose . • Jacksonville, • Miami • Boston • Seattle, WA •Atlanta •Denver Do not state that the company has offices, warehouses, distributors or physical operations in these locations unless specifically provided. Company Details Company: PRIMECARE IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone/Whatsapp: +91 9673008130 PRIMECARE IMPEX is an India based pharmaceutical export and B2B sourcing Company for global pharmaceutical enquiries. Suggested URL Slug Introduction Paclitaxel Injection Product Overview PACLITAX-100MG/16.7ML Product Specifications Paclitaxel Injection Description Pharmaceutical Exporter from India to USA Pharmaceutical Supplier USA Oncology and Anticancer Pharmaceutical Export India-to-USA Pharmaceutical Export Process USA Pharmaceutical Import Considerations Documentation and Compliance Overview Pharmaceutical Sourcing from India Paclitaxel Injection Procurement Enquiries USA Location-Based Pharmaceutical Export Sections Why Choose an India-Based Pharmaceutical Exporter? B2B Pharmaceutical Supply Enquiries Frequently Asked Questions Conclusion Contact PRIMECARE IMPEX SEO Requirements Use secondary keywords naturally throughout the article. Maintain professional pharmaceutical B2B language, clear headings, short paragraphs, bullet points and informative content. Do not overuse keywords or create spammy city/location pages. Because this article targets the USA, do not claim or imply FDA approval, FDA registration, US marketing authorization, unrestricted US sale, or legal eligibility for import unless verified for the specific product and company. Explain that pharmaceutical importation and distribution in the USA are subject to applicable FDA requirements, importer responsibilities, product authorization requirements, state/federal regulations and other applicable laws. Do not provide medical advice, dosage recommendations, treatment instructions, or claims that the product is suitable for individual patients. Include at least 15 SEO-friendly FAQs, such as: What is PACLITAX-100MG/16.7ML Paclitaxel Injection? What is paclitaxel injection used for? How can I source paclitaxel injection from India? Is PRIMECARE IMPEX a pharmaceutical exporter from India? Can I make a Paclitaxel Injection supply enquiry from the USA? What documents are required for pharmaceutical imports into the USA? Can pharmaceutical buyers in New York contact an Indian exporter? Does PRIMECARE IMPEX support pharmaceutical enquiries from California? How can USA pharmaceutical companies contact an Indian supplier? What should buyers verify before importing pharmaceutical products into the USA? Tone Write for: US pharmaceutical importers, distributors, wholesalers, procurement companies, healthcare supply businesses and qualified B2B buyers. The content should be authoritative, informative, trustworthy and suitable for a professional pharmaceutical export website. Avoid exaggerated claims such as “best supplier,” “100% FDA approved,” “guaranteed delivery,” “cheapest supplier,” or similar unsupported statements. End with a strong but compliant B2B pharmaceutical export enquiry call-to-action for PRIMECARE IMPEX.

PACLIAQUALIP-100 MG Paclitaxel – Pharma Exporter India USA Primecare Impex is an India based pharmaceutical exporter helping professional pharmaceutical export enquiries from India to USA. We offer B2B pharmaceutical sourcing and export inquiry to buyers, importers, distributors, wholesalers and pharmaceutical procurement companies across the United States. PACLIAQUALIP-100 MG Paclitaxel Product: PACLIAQUALIP 100 MG Active Ingredient: Paclitaxel Strength: 100mg Dosage Form: Suspension, Injection Presentation: Vial Category: Oncological / Antineoplastic Drug Origin: India Primecare Impex welcomes professional enquiries for Paclitaxel 100 MG pharmaceutical products and India-to-USA pharmaceutical sourcing. India to the USA Pharmaceutical Exporter Looking for a pharmaceutical exporter from India to the USA? Primecare Impex invites product enquiries from U.S. pharmaceutical buyers and professional organisations. Our services include: Pharmaceutical exporter India USA Pharmaceutical Supplier United States Indian pharmaceutical provider Pharmaceutical exporter of Paclitaxel India exporter of oncological drugs Pharmaceutical procurement from India India to USA pharmaceutical export service Pharmaceutical B2B export queries We take calls from New York, New Jersey, California, Texas, Florida, Illinois, Pennsylvania, Massachusetts, Georgia, Washington and other U.S. states. Pharmaceutical Manufacturer India Paclitaxel Primecare Impex can receive enquiries for PACLIAQUALIP-100 MG Paclitaxel 100 MG vial. For quotation enquiries, please provide: Product + Quantity + U.S. Destination + Company Name + Importer Details Confirm product specifications, documentation, availability and regulatory status before any commercial transaction. USA Pharmaceutical Import The FDA requirements apply to pharmaceutical imports to the U.S. Depending on the product, requirements may include: establishment registration, drug listing, applicable drug application, labelling and cGMP compliance. This page does not provide information on the FDA approval status andauthorization for sale in the US of PACLIAQUALIP-100 MG. U.S. purchasers should confirm the appropriate FDA status and import requirements for the product in question. Why to Choose Primecare Impex? Pharmaceutical exporter based in India Global pharmaceutical procurement support Pharmaceutical B2B Queries Product and business inquiry assistance Pharmaceuticals: USA export enquiries Questions on paclitaxel and oncology products Primecare Impex Contact Us PRIMECARE IMPEX Exporter of Pharmaceuticals, India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone / WhatsApp: +91 9673008130 USA Pharmaceutical Export Inquiry PACLIAQUALIP-100 MG | Paclitaxel 100 MG | Injection For professional pharmaceutical sourcing and export enquiries, please contact Primecare Impex, subject to product availability and U.S. regulatory requirements. Primary SEO Keywords PACLIAQUALIP-100 MG, Paclitaxel 100 MG, Supplier Paclitaxel India, Exporter Paclitaxel India, Exporter of Pharmaceutical India USA, Supplier of Pharmaceutical India, Supplier of Pharmaceutical India USA, Indian Supplier of Pharmaceutical India USA, Exporter of Pharmaceutical India Oncology, Exporter of Pharmaceutical India to USA, Pharmaceutical Sourcing India, Pharmaceutical B2B Supplier India, Exporter of Pharmaceutical Paclitaxel. PACLIAQUALIP-100 MG Paclitaxel Exporter India to USA | Primecare Impex PACLIAQUALIP-100 MG Paclitaxel 100 MG vial. Primecare Impex is assisting in professional pharmaceutical export and sourcing enquiries from India to USA. URL Slug /paclialqualip-100-mg-paclitaxel-exporter-india-usa/

Oxaliplatin 100mg/20ml Injection Exporters in India to UK Primecare Impex Pharmaceutical Export Services From India To Uk Primecare Impex helps with international pharmaceutical sourcing and export enquiries from India including from businesses and healthcare sector buyers in London, Birmingham, Manchester, Glasgow, Liverpool and Leeds. Oxaliplatin Injection 100 mg/20 ml Oxaliplatin 100mg/20ml is an oncology medicine that contains 100mg of oxaliplatin in a 20 mL vial, equivalent to a concentration of 5mg/mL. Oxaliplatin 5 mg/mL concentrate for solution for infusion, UK medicines information. Oxaliplatin is an anti-neoplastic drug used in specialist oncology treatment. In the UK, product information describes use, including in combination with other medicines, for specified indications in colorectal cancer. “The administration and preparation of oxaliplatin requires appropriately trained health care professionals and specialist facilities.” Product Specifications Specification Details Oxaliplatin Injection Product Strength 100 mg/20 mL Concentration 5 mg/mL Dosage form Concentrate for solution for infusion Active ingredient Oxaliplatin Pack 20 mL vial Therapeutic class Antineoplastic / oncology agent Supply subject to applicable pharmaceutical export and import requirements Pharmaceutical export services from India to the UK Primecare Impex manages export enquiries for pharmaceuticals from India for international buyers looking for pharmaceutical products and sourcing support. We are able to help with export enquiries for the UK including: London Birmingham Manchester Glasgow Liverpool Leeds Check the relevant regulatory, licensing, import, wholesale distribution and product authorisation requirements for pharmaceutical shipments to the UK before an order is fulfilled. The UK authorities say that importation of human medicines may require appropriate licensing, such as a Wholesale Distribution Authorisation and other authorisations, as appropriate, depending on the circumstances. Pharmaceutical Oxaliplatin Supplier and Exporter from India If you are looking for an Oxaliplatin 100mg/20ml supplier in India, Oxaliplatin injection exporter or oncology pharmaceutical exporter to UK, you can get in touch with Primecare Impex to discuss product availability, specifications, documentation and export requirements. We invite prospective buyers in the UK to share their company details, destination, quantity and regulatory requirements for assessing the applicable export documentation and supply process. India Pharmaceutical Exporter to London and Birmingh Primecare Impex welcomes enquiries for pharmaceutical exports from companies in Birmingham, London and other UK locations, including Manchester, Glasgow, Liverpool and Leeds. Supply of regulated medicines such as oxaliplatin into the UK should only be via the appropriate authorised routes and in accordance with UK medicines regulations. Request Oxaliplatin Export Inquiry For queries related to Oxaliplatin 100mg/20ml injection, pharma sourcing from India or India to UK pharma export services, get in touch with Primecare Impex. Primecare Impex Email: raakeshkashiwar@gmail.com Phone/WhatsApp: +91 9673008130 Website: www.medicineexporterfromindia.com

DACOTIN-100MG Oxaliplatin Product Information Product Name: DACOTIN 100MG Active Ingredient: Oxaliplatin Strength: 100mg Formulation: Powder for Solution for Infusion Product Category: Pharmaceuticals / Antineoplastic / Oncology Market: UK and international pharmaceutical markets subject to applicable regulatory requirements DACOTIN-100MG contains oxaliplatin which is a platinum based antineoplastic drug. The product is supplied as a powder for reconstitution for intravenous infusion according to approved product information and applicable healthcare protocols. Buyers are advised to check the current regulatory status, marketing authorisation, packaging, labelling, documentation and import requirements of the product prior to ordering for the UK market. Pharmaceutical Export Support – India to UK When sourcing pharmaceutical products from India, organisations looking for a pharmaceutical supplier UK may need to coordinate with the exporter, importer, distributor and relevant regulatory authorities. We are able to support pharmaceutical export enquiries for product DACOTIN-100MG and would be happy to discuss requirements with prospective UK buyers. Our service may include co-ordination of inquiry for: Requirements for product and strength Pharmaceutical product specifications Commercial quotes Documents for export Packaging and Shipping Conversations Requirements of buyers and importers UK-specific requirements for market documentation All imports of pharmaceuticals into the UK should be undertaken by parties who are appropriately authorised and in compliance with relevant UK regulations. Pharmaceutical Exporter India UK Medicine Exporter from India, International Inquiry Channel for Pharmaceutical Sourcing from India. If your organization is based in London, Birmingham, Glasgow, Manchester, Liverpool or Leeds then please get in touch to discuss your pharmaceutical sourcing needs. For UK pharmaceutical purchase requests please provide the relevant product name, strength, quantity, destination and any relevant buyer/importer requirements so that the request can be reviewed appropriately. DACOTIN-100MG Pharmaceutical Export Inquiry Please contact our pharmaceutical export department if you have any enquiries about DACOTIN-100MG Oxaliplatin Powder for Solution for Infusion. Corporate Contact: www.medicineexporterformindia.com Mobile/WhatsApp: +91 9673008130 Email: raakeshkashiwar@gmail.com Website: www.medicineexporterformindia.com You can also contact us on WhatsApp for pharmaceutical export queries. DACOTIN-100MG Oxaliplatin India UK hormone exporter pharmaceuticals Note: “hormone pharmaceutical exporter India UK” should only be used on relevant company/service content covering hormone-related pharmaceutical products. This is not intended to be a description of Oxaliplatin Oxaliplatin DACOTIN-100MG Exporter India to UK | Pharma Supplier Oxaliplatin (DACOTIN-100MG) from India. For UK pharmaceutical export enquiries. Serving buyers and pharmaceutical sourcing enquiries across London, Birmingham, Glasgow and further afield. Suggested URL Slug /dacotin-100mg-oxaliplatin-exporter-in-india-uk/ What is DACOTIN 100 MG? DACOTIN-100MG is a pharmaceutical preparation of oxaliplatin 100 mg powder for solution for infusion. Is DACOTIN-100MG available in UK? We welcome enquiries from UK based buyers for Pharmaceutical Exports. Actual supply to the UK will depend on product availability, applicable regulatory requirements, importer authorisation and other UK pharmaceutical import requirements. Do you provide pharmaceutical export services from India to UK? Yes. We facilitate UK-based pharmaceutical sourcing and export enquiries from places including London, Birmingham, Glasgow, Manchester, Liverpool and Leeds. Question: Is oxaliplatin a hormone drug? No. Oxaliplatin is an antineoplastic chemotherapy agent. It should not be called a hormone pharmaceutical. How do I make an inquiry for UK buyers? UK buyers can contact us by phone, WhatsApp or email stating the name of the product, the strength you require, the quantity and details of the destination. Contact us Pharmaceutical Exporter India – UK Contact Medicine Exporter in India For DACOTIN-100MG Oxaliplatin Pharmaceutical Export Enquiries: Phone / WhatsApp : +91 9673008130 Email : raakeshkashiwar@gmail.com Served pharmaceutical export enquiries London wide • Birmingham • Glasgow • Manchester • Liverpool • Leeds • Newcastle

Vincristine Sulphate Injection Oncovin 1 mg – India to UK Pharmaceutical Export Service Pharmaceutical Supplier UK – Vincristine Sulphate Injection Are you looking for a UK pharmaceutical supplier to answer questions about Oncovin 1 mg Vincristine Sulphate Injection? We are based in India and our pharmaceutical export service caters to B2B pharmaceutical enquiries from authorised healthcare, procurement and pharmaceutical organisations across the United Kingdom. We support pharmaceutical export enquiries across London, Birmingham, Manchester, Glasgow, Liverpool and Leeds subject to applicable UK import, licensing and product requirements. Vincristine Sulphate Injection Oncovin 1 mg Product: Oncovin (vincristine sulphate) Injection 1mg Active Ingredient: Vincristine sulphate. Strength: 1mg Strength: Injection Therapeutic class: Vinca alkaloid/antineoplastic agent India Export Source: Target market UK Vinca alkaloid, vincristine sulphate, antineoplastic agent. Vincristine sulphate injection is described in the UK product information as a medicine used in specialist cancer treatment and is for intravenous use only. Given vincristine’s status as a cytotoxic medicine with important precautions for administration and handling, product supply and importation should be undertaken by appropriately licensed pharmaceutical organisations and qualified healthcare professionals. Description Product Oncovin 1 mg Injection Vincristine Sulphate is a pharmaceutical formulation of vincristine sulphate, an antineoplastic vinca alkaloid. Vincristine acts on microtubules to inhibit cell division and is included in oncology treatment protocols. The UK Summary of Product Characteristics for vincristine sulphate injection provides therapeutic use in a range of haematological malignancies and solid tumours and provides detailed professional information concerning administration, contraindications, warnings and handling. Pharmaceutical Export Services UK from India Our India to UK pharmaceutical export services are for genuine B2B pharmaceutical enquiries for sourcing and exporting pharmaceutical products. Subject to applicable regulations and documentation. The requirements for importing into the UK may depend on the regulatory status of the medicine. To import human medicines into the UK you may need the appropriate licences, says the MHRA. This includes a Wholesale Distribution Authorisation, manufacturer/importer authorisation and where applicable a marketing authorisation. Pharmaceutical Export Enquiries (UK-wide) We accept pharmaceutical export enquiries from organisations located in: London • Birmingham • Manchester • • Glasgow. • Liverpool • Leeds This is a professional B2B service and not a direct-to-patient sale. Product Inquiry – Pharmaceutical Supplier UK If you are an organization seeking information on Oncovin 1 mg Vincristine Sulphate Injection or other pharmaceutical products for the UK market, please contact our export team with your product requirements and destination details. Availability, regulatory paperwork, export eligibility and commercial terms are to be confirmed on an individual inquiry basis. Get in touch with our Export Team Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone / WhatsApp: +91 9673008130 WhatsApp: Chat to us on WhatsApp+919673008130 UK Pharmaceutical Importation Compliance Medicines imported into the UK are regulated. Requirements vary depending on a number of factors, including whether the medicine is licensed or unlicensed and the country it is imported from, says the MHRA. UK wholesalers supplying human medicines usually require the relevant wholesale distribution authorisation and there may be additional requirements for imports and marketing authorisations. UK organisations should check the relevant requirements before placing an import or supply order. The MHRA also keeps registers of licensed wholesale distribution sites and other pharmaceutical regulatory information. Oncovin 1 mg Vincristine Injection | UK Pharmaceutical Supplier India to UK pharmaceutical export services for Oncovin 1 mg Vincristine Sulphate Injection. Professional B2B pharmaceutical enquiries across London, Birmingham and the UK

Neophos 1000 mg Cyclophosphamide Injection Vial - Pharmaceuticals Exporter from India to United Kingdom Neophos 1000 mg Cyclophosphamide Injection Vial is a drug that contains cyclophosphamide , an alkylating agent used in specialist medical settings. Based in India, our pharmaceutical export service helps qualified pharmaceutical buyers, distributors, wholesalers and healthcare procurement organisations looking for information on pharmaceutical supply from India to the UK. Pharmaceutical Export Services from India to UK We handle pharmaceutical export enquiries from all over the United Kingdom including: London Birmingham Manchester Liverpool Leeds Glasgow Our India to UK Pharmaceutical Export Services are for professional B2B enquiries and can help with product information, availability enquiries, documentation requirements and export co-ordination, subject to applicable Indian and UK Regulatory Requirements. Product Specifications – Cyclophosphamide Injection Vial Neophos 1000 mg Brand: Neophos 1000 mg Injection Active ingredient: Cyclophosphamide Strength 1000 mg Type of administration: Powder for solution for injection/infusion Product group: Cytotoxic drug / Antineoplastics Packaging Vial, as per manufacturer and presentation in the market Supply: Export enquiries for pharmaceuticals B2B Country of Origin: India Prior to ordering, the supplier should be contacted for product specifications, pack presentation, registration status, batch documentation and availability. Pharmaceutical export support from India to the UK Looking for a pharmaceutical supplier for UK procurement? We provide export inquiry support from India for pharmaceutical products including specialist medicines such as cyclophosphamide injection subject to applicable licensing, product registration and import requirements. UK importers should independently verify the regulatory status of any medicinal product prior to importation or supply. UK importers may need to hold appropriate authorisations, including a Wholesale Distribution Authorisation (WDA(H)), manufacturer/importer authorisation or other appropriate permissions depending on the product and circumstances, according to the MHRA. For unlicensed medicines further MHRA requirements and notification procedures may apply. Cyclophosphamide Injection Manufacturer India If you are looking for a supplier of cyclophosphamide injection from India, then contact us for product and pharmaceutical export enquiries. We can provide the requirements for Neophos 1000 mg cyclophosphamide injection vial, if available, manufacturer documentation, destination-market requirements and applicable regulatory approvals. Cyclophosphamide is a cytotoxic pharmaceutical product and a prescription medicine. It should be dealt with, provided and administered only by appropriately authorised and qualified professionals. India to UK Pharmaceutical Exporter We are an India based pharmaceutical export contact supporting B2B enquiries from buyers and pharmaceutical organisations in London, Birmingham, Manchester, Liverpool, Leeds and Glasgow. We do not sell medicine direct to consumers, our services are geared toward professional pharmaceutical procurement and export queries. For Enquiries on Pharmaceutical Exports Website: medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone / WhatsApp: +91 9673008130 Neophos 1000 mg Cyclophosphamide Injection India to UK Pharmaceutical Exporter Buy Neophos 1000 mg cyclophosphamide injection vial and India to UK pharmaceutical export services for qualified pharmaceutical buyers and importers.

What is MyHep Tablet (Sofosbuvir 400 mg)? MyHep Tablet 400 mg contains Sofosbuvir 400 mg, a highly effective antiviral medicine used in the treatment of chronic Hepatitis C Virus (HCV) infection. It belongs to a class of medicines known as direct-acting antivirals (DAAs) and is prescribed as part of combination therapy, depending on the HCV genotype and the patient's clinical condition. Modern Hepatitis C treatment with Sofosbuvir has significantly improved cure rates while reducing treatment duration compared with older interferon-based therapies. Many treatment regimens achieve sustained virologic response (SVR), meaning the virus becomes undetectable after treatment when used appropriately under medical supervision. Product Headline MyHep Tablet (Sofosbuvir 400 mg) – Advanced Antiviral Medicine for Chronic Hepatitis C Treatment Product Profile Product Name: MyHep Tablet Generic Name: Sofosbuvir Strength: 400 mg Dosage Form: Oral Tablet Packing: 28 Tablets (1 Bottle) Category: Antiviral Medicine Therapeutic Class: Direct Acting Antiviral (DAA) Primary Use: Treatment of Chronic Hepatitis C Virus (HCV) Infection How Sofosbuvir Works Sofosbuvir works by inhibiting the NS5B RNA-dependent RNA polymerase, an enzyme required for Hepatitis C virus replication. Step-by-step process: Step 1 After oral administration, Sofosbuvir is absorbed into the bloodstream. Step 2 Inside liver cells, it is converted into its active metabolite. Step 3 The active metabolite blocks the viral NS5B polymerase. Step 4 The Hepatitis C virus is unable to replicate effectively. Step 5 The viral load decreases over time, allowing the immune system to clear the infection when the full treatment regimen is completed. tep-by-Step Treatment Process Step 1 – Medical Evaluation Your healthcare provider confirms Hepatitis C infection and assesses liver health. Step 2 – Laboratory Testing Testing may include: HCV RNA Liver function tests Kidney function tests HCV genotype (where applicable) Step 3 – Treatment Selection A suitable antiviral combination regimen is selected. Step 4 – Daily Medication Take MyHep Tablet consistently as directed. Step 5 – Monitoring Periodic blood tests help monitor treatment response and safety. Step 6 – Completion Complete the prescribed course. Step 7 – Follow-Up A follow-up HCV RNA test is typically performed after treatment to evaluate sustained virologic response (SVR). Benefits of MyHep Tablet Modern direct-acting antiviral therapy High cure rates when used in appropriate combination regimens Once-daily dosing Well-established efficacy in recommended patient groups Interferon-free options in many treatment protocols Supports long-term viral clearance when treatment is completed as prescribed Can MyHep Tablet cure Hepatitis C? When used as part of an appropriate treatment regimen prescribed by a healthcare professional, many patients achieve sustained virologic response (SVR), which is considered a functional cure. Can I stop treatment once I feel better? No. Complete the full prescribed course unless your healthcare provider advises otherwise. Can I take MyHep Tablet with food? Yes. It may generally be taken with or without food unless your healthcare provider gives different instructions. Is monitoring necessary? Yes. Regular medical follow-up and laboratory monitoring are important throughout treatment. Why Choose Primecare Impex? Primecare Impex is committed to providing quality pharmaceutical products with a focus on customer support and international supply standards. Highlights include: Pharmaceutical exporter from India Quality-focused sourcing Professional customer support Reliable product handling International supply experience Responsive communication Timely documentation support Contact Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Myhep DVIR Tablet contains Daclatasvir 60 mg and Sofosbuvir 400 mg film-coated tablets for the treatment of chronic Hepatitis C Virus (HCV) infection. Learn about indications, dosage, mechanism of action, safety, storage, and product information from Primecare IMPEX. Myhep DVIR Tablet Daclatasvir 60 mg + Sofosbuvir 400 mg Film-Coated Tablets Product Overview Myhep DVIR Tablet is a fixed-dose antiviral medicine containing Daclatasvir 60 mg and Sofosbuvir 400 mg. This combination belongs to the class of Direct-Acting Antiviral (DAA) medicines used in the treatment of chronic Hepatitis C Virus (HCV) infection in adults. The combination targets different stages of viral replication, helping reduce the viral load and supporting sustained virologic response (SVR) when prescribed by a qualified healthcare professional. Product Profile Brand Name: Myhep DVIR Tablet Generic Composition Daclatasvir 60 mg Sofosbuvir 400 mg Dosage Form Film-Coated Tablet Strength 60 mg / 400 mg Packing 28 Tablets 1 Bottle Therapeutic Category Direct-Acting Antiviral (DAA) Primary Use Treatment of Chronic Hepatitis C Virus (HCV) Infection Myhep DVIR Tablet is prescribed for the treatment of chronic Hepatitis C Virus infection in adults when recommended by a physician. Depending on viral genotype, liver condition, prior treatment history, and current clinical guidelines, treatment duration and combinations may vary. Healthcare providers typically evaluate: HCV genotype Liver function Viral load Previous treatment history Presence of liver cirrhosis Co-existing medical conditions Potential drug interactions The medicine should only be used under medical supervision. How Myhep DVIR Works Myhep DVIR combines two antiviral medicines that attack different proteins essential for Hepatitis C virus replication. Sofosbuvir Sofosbuvir inhibits the NS5B RNA-dependent RNA polymerase, an enzyme required for viral RNA replication. By blocking this enzyme, viral multiplication is significantly reduced. Daclatasvir Daclatasvir inhibits the NS5A protein. NS5A plays an important role in viral replication and viral assembly. Blocking NS5A prevents the virus from producing new infectious particles. Dual Mechanism Working together, Daclatasvir and Sofosbuvir reduce viral replication, lower circulating viral levels, and improve the likelihood of achieving a sustained virologic response (SVR), often referred to as a virologic cure. Primecare IMPEX is engaged in supplying pharmaceutical products with a focus on product quality, appropriate documentation, and customer support. Customers value: Quality-focused pharmaceutical products Professional customer assistance Secure packaging Timely communication International supply experience Product documentation support Responsive service Product Specifications Product Name: Myhep DVIR Tablet Generic Name: Daclatasvir 60 mg + Sofosbuvir 400 mg Dosage Form: Film-Coated Tablet Strength: 60 mg / 400 mg Pack Size: 28 Tablets per Bottle Therapeutic Category: Antiviral Medicine Indication: Treatment of Chronic Hepatitis C Virus (HCV) Infection under medical supervision. Frequently Asked Questions (FAQ) What is Myhep DVIR Tablet used for? It is used in the treatment of chronic Hepatitis C Virus infection when prescribed by a qualified healthcare professional. How does Myhep DVIR work? It combines Daclatasvir and Sofosbuvir, two direct-acting antivirals that inhibit different proteins required for HCV replication. Can the tablet be taken with food? Yes. It may generally be taken with or without food, following your healthcare provider's advice. How long is treatment? Treatment duration depends on the patient's condition, viral genotype, liver status, and physician recommendation. Is medical supervision necessary? Yes. This medicine should only be taken under the supervision of a qualified healthcare professional. Contact Primecare IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130 Medical Disclaimer This information is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Myhep DVIR Tablet should only be used under the supervision of a qualified healthcare professional and in accordance with approved prescribing information.

MyhepAll Tablet (Sofosbuvir 400 mg + Velpatasvir 100 mg) | Hepatitis C Medicine Guide | Primecare IMPEX arn about MyhepAll Tablet containing Sofosbuvir 400 mg and Velpatasvir 100 mg, its uses, dosage, mechanism of action, safety information, storage, and product profile. Complete patient guide from Primecare IMPEX. MyhepAll Tablet – Sofosbuvir 400 mg + Velpatasvir 100 mg Product Headline MyhepAll Tablet (Sofosbuvir 400 mg + Velpatasvir 100 mg) – Complete Oral Antiviral Therapy for Chronic Hepatitis C Virus (HCV) Infection Product Profile Brand Name: MyhepAll Tablet Generic Name: Sofosbuvir 400 mg + Velpatasvir 100 mg Dosage Form: Film-Coated Tablet Strength: Sofosbuvir 400 mg Velpatasvir 100 mg Packing Size: 28 Tablets (1 Bottle) Therapeutic Category: Direct-Acting Antiviral (DAA) Primary Use: Treatment of Chronic Hepatitis C Virus (HCV) Infection What is MyhepAll Tablet? MyhepAll Tablet is an oral prescription medicine that combines two direct-acting antiviral agents—Sofosbuvir and Velpatasvir. The combination is used for the treatment of chronic hepatitis C virus (HCV) infection in appropriate patients as determined by a qualified healthcare professional. The combination is designed to target different stages of the viral replication process, helping suppress the hepatitis C virus. Treatment duration varies depending on factors such as viral genotype, liver condition, previous treatment history, and the treating clinician's assessment. MyhepAll Tablet is indicated for the treatment of chronic Hepatitis C Virus (HCV) infection in adults and, where approved by local regulations, certain pediatric populations. It may be prescribed for patients with: • Chronic Hepatitis C infection • Multiple HCV genotypes where clinically appropriate • Compensated liver disease • Selected patients with advanced liver disease under specialist supervision • Patients receiving treatment according to current clinical guidelines Healthcare professionals determine treatment duration and whether additional medicines are required based on individual clinical factors. Benefits of MyhepAll Tablet • Once-daily oral administration • Combines two antiviral medicines in one tablet • Targets different stages of viral replication • Used as part of evidence-based HCV treatment protocols • Convenient 28-tablet bottle packaging 2. Mechanism of Action – How MyhepAll Tablet Works Sofosbuvir Sofosbuvir is an NS5B nucleotide polymerase inhibitor. It blocks the viral RNA polymerase enzyme required for hepatitis C virus replication. Without this enzyme, the virus cannot efficiently produce new copies of itself. Velpatasvir Velpatasvir is an NS5A inhibitor. It interferes with viral replication and viral assembly by targeting the NS5A protein, an essential component of the hepatitis C viral life cycle. Dual Mechanism The combination attacks two separate viral targets: • NS5B Polymerase • NS5A Protein This complementary mechanism is why the combination is widely used in modern hepatitis C treatment regimens. Who Should Consult a Doctor Before Taking MyhepAll? Medical consultation is particularly important for individuals with: • Liver disease • Kidney disease • Previous hepatitis treatment • Hepatitis B infection • HIV co-infection • Pregnancy or plans for pregnancy • Breastfeeding • Organ transplantation history Frequently Asked Questions What is MyhepAll Tablet used for? It is a prescription medicine used in the treatment of chronic Hepatitis C Virus (HCV) infection under the supervision of a qualified healthcare professional. How many tablets are in one bottle? One bottle contains 28 tablets. Can it be taken with food? It is generally taken once daily and may be taken with or without food, according to prescribing information and medical advice. Is this a prescription medicine? Yes. MyhepAll Tablet should only be used under the guidance of a qualified healthcare professional. Why Choose Primecare IMPEX? Primecare IMPEX is committed to providing quality pharmaceutical information and reliable customer support. Why people choose Primecare IMPEX: • Patient-focused information • Professional customer assistance • Reliable communication • Transparent product information • International customer support • Timely response to enquiries Contact Primecare IMPEX Primecare IMPEX Business Type Exporter | Supplier | Distributor Website www.medicineexporterfromindia.com Email raakeshkashiwar@gmail.com WhatsApp +91 9673008130 WhatsApp https://wa.me/919673008130